WILLIAM BACHMAN: Open Payments
NPI 1245851039 · NOVI, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 52 payments from 16 companies in 2025. Trend: 2023 $71 · 2024 $453 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $280 |
| AstraZeneca Pharmaceuticals LP | 9 | $156 |
| Lilly USA, LLC | 8 | $135 |
| PFIZER INC. | 5 | $85 |
| Exact Sciences Corporation | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $49 |
| Corcept Therapeutics | 1 | $45 |
| Abbott Laboratories | 2 | $40 |
| Hologic Sales and Service, LLC | 1 | $25 |
| Olympus America Inc. | 1 | $24 |
Products named: Wegovy, Rybelsus, JARDIANCE, AIRSUPRA, MOUNJARO, Ozempic, PREVNAR 20, The Cologuard Plus Collection Kit.
Industry payments across MI — which companies pay providers there.
